200 related articles for article (PubMed ID: 35144337)
1. [Impact of neoadjuvant immunotherapy on pulmonary function and perioperative outcomes in patients with resectable non-small cell lung cancer].
Zhu Y; Li JQ; Chang Q; Qiang HP; Lu JH; Feng H; Shen YC; Qian JL; Chu TQ
Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):393-398. PubMed ID: 35144337
[No Abstract] [Full Text] [Related]
2. Effect of Neoadjuvant Immunotherapy Combined with Chemotherapy on Pulmonary Function and Postoperative Pulmonary Complications in Esophageal Cancer: A Retrospective Study.
Gao Y; Zhang H; Qiu Y; Bian X; Wang X; Li Y
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38310460
[TBL] [Abstract][Full Text] [Related]
3. Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer.
Shen J; Gu L; Qi Y; Yao Y; Lu S; Chen Z
Front Immunol; 2023; 14():1268251. PubMed ID: 37818382
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of circulating tumor cells in monitoring the efficacy of neoadjuvant immunotherapy for non-small cell lung cancer].
Li YJ; Chen H; Liao JF; Yuan JL; Chen T; Zhu J
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Feb; 55(2):233-238. PubMed ID: 34645185
[No Abstract] [Full Text] [Related]
5. [Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with
Chemotherapy in Resectable Non-small Cell Lung Cancer].
Zhou S; Hao X; Yu D; Liu S; Cao X; Su C; Song X; Xiao N; Li Y; Yang W; Zhao D; Wang J; Liu Z; Xu S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):420-425. PubMed ID: 34024062
[TBL] [Abstract][Full Text] [Related]
6. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
Leo F; Solli P; Spaggiari L; Veronesi G; de Braud F; Leon ME; Pastorino U
Ann Thorac Surg; 2004 Jan; 77(1):260-5; discussion 265. PubMed ID: 14726074
[TBL] [Abstract][Full Text] [Related]
7. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
Li L; Liu Y; Li J; Gao JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
[No Abstract] [Full Text] [Related]
8. Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer.
Shin S; Choi YS; Jung JJ; Im Y; Shin SH; Kang D; Cho JH; Kim HK; Kim J; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Lee G; Cho J; Lee HY; Park HY
Respir Res; 2020 Jan; 21(1):13. PubMed ID: 31924201
[TBL] [Abstract][Full Text] [Related]
9. Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function.
He YY; Chen Z; Fang XY; Chang J; Lu Y; Wang XJ
BMC Endocr Disord; 2020 Jul; 20(1):112. PubMed ID: 32703207
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of neoadjuvant immunotherapy in resectable nonsmall cell lung cancer: A meta-analysis.
Jia XH; Xu H; Geng LY; Jiao M; Wang WJ; Jiang LL; Guo H
Lung Cancer; 2020 Sep; 147():143-153. PubMed ID: 32717571
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC.
Mao Z; Pang G; Huang X; Chen X; Wu J; Xu X; Teng Z; Tan Y; Wang P
BMC Pulm Med; 2024 May; 24(1):253. PubMed ID: 38783253
[TBL] [Abstract][Full Text] [Related]
13. Chest wall resection for non-small cell lung cancer: A case-matched study of postoperative pulmonary function and quality of life.
Liu M; Wampfler JA; Dai J; Gupta R; Xue Z; Stoddard SM; Cassivi SD; Jiang G; Yang P
Lung Cancer; 2017 Apr; 106():37-41. PubMed ID: 28285692
[TBL] [Abstract][Full Text] [Related]
14. Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD).
Zeng A; Yin Y; Xu Z; Abuduwayiti A; Yang F; Shaik MS; Wang C; Chen K; Wang C; Fang X; Dai J
BMC Cancer; 2024 Mar; 24(1):396. PubMed ID: 38553708
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
16. The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.
Jiang L; Huang J; Jiang S; Rong W; Shen Y; Li C; Tian Y; Ning J; Chen X; Yang Y; Ding Z; Li Z; Luo Q
Cancer Immunol Immunother; 2021 Aug; 70(8):2313-2321. PubMed ID: 33512555
[TBL] [Abstract][Full Text] [Related]
17. [Study on changes of pulmonary function in patients with pneumoconiosis in three years].
Li X; Dai WR; Liu WF; Yang ZX; Xie L; Wu ZY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Dec; 38(12):891-894. PubMed ID: 33406545
[No Abstract] [Full Text] [Related]
18. Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study.
Zhou S; Liu Y; Liu K; Zhang J; Liang H; Wu Y; Ye H; Liang Y; Zhang J; Huang W
Front Immunol; 2023; 14():1343504. PubMed ID: 38187385
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary function in chronic heart failure. Changes after heart transplantation.
Ulrik CS; Carlsen J; Arendrup H; Aldershvile J
Scand Cardiovasc J; 1999; 33(3):131-6. PubMed ID: 10399799
[TBL] [Abstract][Full Text] [Related]
20. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
